SCHEMBL7973628

SCHEMBL7973628

O=c1nc(-c2cccc(Cl)c2)[nH]c2ncn(Cc3cccc(Cl)c3)c12

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
GLA P06280 1/20 0.48
HTT P42858 1/20 0.48
UBE2N P61088 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ACP1 P24666 2/20 0.44
PARN O95453 1/20 0.44
CNOT7 Q9UIV1 1/20 0.44
CXCR2 P25025 1/20 0.44
YTHDC1 Q96MU7 2/20 0.43
MAPK1 P28482 1/20 0.43
PIK3CD O00329 1/20 0.43
PIK3CB P42338 1/20 0.43
FSCN1 Q16658 1/20 0.42
IDO1 P14902 1/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
PGR P06401 1/20 0.41
P2RX7 Q99572 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974015 0.96 PARN (0.49) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7988669 0.94 PARN (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7991568 0.94 SMN1; SMN2 (0.45) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7987312 0.93 GRIN1 (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7975243 0.93 HTT (0.44) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7985362 0.93 GRIN1 (0.45) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7991647 0.93 SMN1; SMN2 (0.44) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7991600 0.90 ACP1 (0.42) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7988784 0.90 MAPK1 (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL8056886 0.90 SMN1; SMN2 (0.46) SMN1; SMN2GLAHTTUBE2NL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed